New Tools Needed to Assess Dysphagia in MS, Review Says
Difficulty swallowing affects about one-third of patients with multiple sclerosis. April 8, 2020 Dysphagia, or difficulty swallowing, after a multiple…
Neurotoxicity After Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Ann Clin Transl Neurol . 2020 Apr 18. doi: 10.1002/acn3.51045. Online ahead of print. Simon Thebault 1, Hyunwoo Lee 2, Gauruv Bose 1, Daniel Tessier 3, Mohammad Abdoli 1, Marjorie Bowman 1, Jason Berard 1, Lisa…
Stuart Schlossman
NARCOMS ENROLLMENT MILESTONE: 700 MULTIPLE SCLEROSIS PARTICIPANTS ENROLLED
**A press release shared with kind permission of our society partner, the Consortium of Multiple Sclerosis Centers (CMSC)** Patient Registry…
Stuart Schlossman
Researchers Identify New Potential Targets for Stopping Nerve Loss in MS
April 13, 2020 Researchers from the Gladstone Institutes, the University of California, San Francisco, and others reported results of studies…
Stuart Schlossman
People with MS and their Healthcare Providers Can Contribute to a Worldwide Research Effort to Improve Coronavirus Outcomes
Click HERE to Register for the MS Beacon Newsletter April 8, 2020 Collaborators around the world are implementing programs for…
Stuart Schlossman
Risk score can predict long-term multiple sclerosis progression
(HealthDay)—A new risk score is capable of predicting long-term multiple sclerosis (MS) progression, according to a study published online March…
Stuart Schlossman
Ursolic Acid, Compound in Fruit Peels, Promotes Myelin Repair, Early Study Finds
Ursolic acid, a compound found in some herbs and in the peels of certain fruits, promoted nerve cell repair and…
Stuart Schlossman
Regular Exercise ‘Strongly Recommended’ to Ease Fatigue in MS: Findings of a Prospective, Observational, and Cross-Sectional Survey.
Kołtuniuk A1, Przestrzelska M2, Karnas A3, Rosińczuk J3. Author information Abstract INTRODUCTION: Multiple sclerosis (MS) is a progressive, chronic inflammatory demyelinating disease of…
Stuart Schlossman
Society-Supported Researchers Target Bile Acid Metabolism in People with MS: Clinical Trial Underway
March 23, 2020 Researchers at Johns Hopkins University report that levels of bile acids (produced by the liver to help…
Stuart Schlossman
Advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Derfuss T1, Mehling M2, Papadopoulou A3, Bar-Or A4, Cohen JA5, Kappos L6. Author information Abstract BACKGROUND: Oral treatment options for disease-modifying therapy in relapsing multiple…
Stuart Schlossman
